Endpoint definition
↥Filter registries Death, Cancer
Check pre-conditions None
Include endpoints None
Check conditions
Apply sex-specific rule None
Extra metadata
diffuse large B-cell lymphoma: Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma (NHL; see this term) in adults characterized by a median age of presentation in the sixth decade of life (but also rarely occurring in adolescents and children) with the initial presentation being single or multiple rapidly growing masses (that may or may not be painful) in nodal or extranodal sites (such as thyroid, skin, breast, gastrointestinal tract, testes, bone, or brain) and that can be accompanied by symptoms of fever, night sweats and weight loss. DLBCL has an aggressive disease course, with the elderly having a poorer prognosis than younger patients, and with relapses being common.
Filter registries Death, Cancer
Check pre-conditions None
Include endpoints None
Check conditions
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Diffuse large B-cell lymphoma based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 327 | 154 | 173 |
Unadjusted prevalence (%) | 0.13 | 0.10 | 0.15 |
Mean age at first event (years) | 64.84 | 63.71 | 65.85 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | - | - | - | - |
15 years | - | - | - | - |
5 years | - | - | - | - |
1 year | - | - | - | - |
Index endpoint: C3_DLBCL – Diffuse large B-cell lymphoma
GWS hits: 0
before Diffuse large B-cell lymphoma
after Diffuse large B-cell lymphoma
Loading survival analyses plot
Loading survival analyses table